CCTA-based coronary plaque quantification and patient care - is it beneficial?
By
HeartFlow
FEATURING
Matthew Budoff
By
HeartFlow
FEATURING
Matthew Budoff
What does CCTA enable in CAD prevention and diagnosis? What does plaque quantification tell us about long term cardiovascular outcomes, and how does it inform risk prevention? Dr. Matthew Budoff discusses the clinical evidence supporting the use of CCTA-based plaque quantification in the diagnosis and management of coronary artery disease.
Comments 2
Login to view comments.
Click here to Login
